ARTICLE | Financial News
Atox Bio closes $23 million in E round
July 24, 2014 11:55 PM UTC
Infectious disease play Atox Bio Inc. (Ness Ziona, Israel) raised an undisclosed amount in the first tranche of a $23 million series E round led by new investor SR One. New investors Lundbeckfond Vent...